A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, and efficacy of medical marijuana or cannabis-containing products for managing symptoms experienced by children with cancer.
White House ‘naloxone summit’ omitting prominent advocates for lower costs
The invite list for the White House’s upcoming “summit” on naloxone pricing and accessibility has some noteworthy omissions. Two of the most prominent organizations focused
June 15, 2023